Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

Deep phenotyping of human induced pluripotent stem cell-derived atrial and ventricular cardiomyocytes.

Cyganek L, Tiburcy M, Sekeres K, Gerstenberg K, Bohnenberger H, Lenz C, Henze S, Stauske M, Salinas G, Zimmermann WH, Hasenfuss G, Guan K.

JCI Insight. 2018 Jun 21;3(12). pii: 99941. doi: 10.1172/jci.insight.99941. [Epub ahead of print]

2.

X-ray diffraction imaging of cardiac cells and tissue.

Nicolas JD, Bernhardt M, Schlick SF, Tiburcy M, Zimmermann WH, Khan A, Markus A, Alves F, Toischer K, Salditt T.

Prog Biophys Mol Biol. 2018 Jun 15. pii: S0079-6107(18)30064-6. doi: 10.1016/j.pbiomolbio.2018.05.012. [Epub ahead of print]

3.

Electrical dysfunctions in human-induced pluripotent stem cell-derived cardiomyocytes from a patient with an arrhythmogenic right ventricular cardiomyopathy.

El-Battrawy I, Zhao Z, Lan H, Cyganek L, Tombers C, Li X, Buljubasic F, Lang S, Tiburcy M, Zimmermann WH, Utikal J, Wieland T, Borggrefe M, Zhou XB, Akin I.

Europace. 2018 Jun 1;20(FI1):f46-f56. doi: 10.1093/europace/euy042.

PMID:
29566126
4.

Ion Channel Expression and Characterization in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes.

Zhao Z, Lan H, El-Battrawy I, Li X, Buljubasic F, Sattler K, Yücel G, Lang S, Tiburcy M, Zimmermann WH, Cyganek L, Utikal J, Wieland T, Borggrefe M, Zhou XB, Akin I.

Stem Cells Int. 2018 Jan 8;2018:6067096. doi: 10.1155/2018/6067096. eCollection 2018.

5.

Correction of diverse muscular dystrophy mutations in human engineered heart muscle by single-site genome editing.

Long C, Li H, Tiburcy M, Rodriguez-Caycedo C, Kyrychenko V, Zhou H, Zhang Y, Min YL, Shelton JM, Mammen PPA, Liaw NY, Zimmermann WH, Bassel-Duby R, Schneider JW, Olson EN.

Sci Adv. 2018 Jan 31;4(1):eaap9004. doi: 10.1126/sciadv.aap9004. eCollection 2018 Jan.

6.

Passive Stretch Induces Structural and Functional Maturation of Engineered Heart Muscle as Predicted by Computational Modeling.

Abilez OJ, Tzatzalos E, Yang H, Zhao MT, Jung G, Zöllner AM, Tiburcy M, Riegler J, Matsa E, Shukla P, Zhuge Y, Chour T, Chen VC, Burridge PW, Karakikes I, Kuhl E, Bernstein D, Couture LA, Gold JD, Zimmermann WH, Wu JC.

Stem Cells. 2018 Feb;36(2):265-277. doi: 10.1002/stem.2732. Epub 2017 Nov 13.

PMID:
29086457
7.

Severe DCM phenotype of patient harboring RBM20 mutation S635A can be modeled by patient-specific induced pluripotent stem cell-derived cardiomyocytes.

Streckfuss-Bömeke K, Tiburcy M, Fomin A, Luo X, Li W, Fischer C, Özcelik C, Perrot A, Sossalla S, Haas J, Vidal RO, Rebs S, Khadjeh S, Meder B, Bonn S, Linke WA, Zimmermann WH, Hasenfuss G, Guan K.

J Mol Cell Cardiol. 2017 Dec;113:9-21. doi: 10.1016/j.yjmcc.2017.09.008. Epub 2017 Sep 21.

8.

Functional correction of dystrophin actin binding domain mutations by genome editing.

Kyrychenko V, Kyrychenko S, Tiburcy M, Shelton JM, Long C, Schneider JW, Zimmermann WH, Bassel-Duby R, Olson EN.

JCI Insight. 2017 Sep 21;2(18). pii: 95918. doi: 10.1172/jci.insight.95918. [Epub ahead of print]

9.

Catecholamine-Dependent β-Adrenergic Signaling in a Pluripotent Stem Cell Model of Takotsubo Cardiomyopathy.

Borchert T, Hübscher D, Guessoum CI, Lam TD, Ghadri JR, Schellinger IN, Tiburcy M, Liaw NY, Li Y, Haas J, Sossalla S, Huber MA, Cyganek L, Jacobshagen C, Dressel R, Raaz U, Nikolaev VO, Guan K, Thiele H, Meder B, Wollnik B, Zimmermann WH, Lüscher TF, Hasenfuss G, Templin C, Streckfuss-Bömeke K.

J Am Coll Cardiol. 2017 Aug 22;70(8):975-991. doi: 10.1016/j.jacc.2017.06.061.

10.

Defined Engineered Human Myocardium With Advanced Maturation for Applications in Heart Failure Modeling and Repair.

Tiburcy M, Hudson JE, Balfanz P, Schlick S, Meyer T, Chang Liao ML, Levent E, Raad F, Zeidler S, Wingender E, Riegler J, Wang M, Gold JD, Kehat I, Wettwer E, Ravens U, Dierickx P, van Laake LW, Goumans MJ, Khadjeh S, Toischer K, Hasenfuss G, Couture LA, Unger A, Linke WA, Araki T, Neel B, Keller G, Gepstein L, Wu JC, Zimmermann WH.

Circulation. 2017 May 9;135(19):1832-1847. doi: 10.1161/CIRCULATIONAHA.116.024145. Epub 2017 Feb 6.

11.

Magnetic Resonance Imaging of Cardiac Strain Pattern Following Transplantation of Human Tissue Engineered Heart Muscles.

Qin X, Riegler J, Tiburcy M, Zhao X, Chour T, Ndoye B, Nguyen M, Adams J, Ameen M, Denney TS Jr, Yang PC, Nguyen P, Zimmermann WH, Wu JC.

Circ Cardiovasc Imaging. 2016 Nov;9(11). pii: e004731.

12.

Hyperthermia Influences the Effects of Sodium Channel Blocking Drugs in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes.

El-Battrawy I, Lang S, Zhao Z, Akin I, Yücel G, Meister S, Patocskai B, Behnes M, Rudic B, Tülümen E, Liebe V, Tiburcy M, Dworacek J, Zimmermann WH, Utikal J, Wieland T, Borggrefe M, Zhou XB.

PLoS One. 2016 Nov 9;11(11):e0166143. doi: 10.1371/journal.pone.0166143. eCollection 2016.

13.

RhoA Ambivalently Controls Prominent Myofibroblast Characteritics by Involving Distinct Signaling Routes.

Jatho A, Hartmann S, Kittana N, Mügge F, Wuertz CM, Tiburcy M, Zimmermann WH, Katschinski DM, Lutz S.

PLoS One. 2015 Oct 8;10(10):e0137519. doi: 10.1371/journal.pone.0137519. eCollection 2015.

14.

Evolutionarily conserved intercalated disc protein Tmem65 regulates cardiac conduction and connexin 43 function.

Sharma P, Abbasi C, Lazic S, Teng AC, Wang D, Dubois N, Ignatchenko V, Wong V, Liu J, Araki T, Tiburcy M, Ackerley C, Zimmermann WH, Hamilton R, Sun Y, Liu PP, Keller G, Stagljar I, Scott IC, Kislinger T, Gramolini AO.

Nat Commun. 2015 Sep 25;6:8391. doi: 10.1038/ncomms9391.

PMID:
26403541
15.

p63RhoGEF regulates auto- and paracrine signaling in cardiac fibroblasts.

Ongherth A, Pasch S, Wuertz CM, Nowak K, Kittana N, Weis CA, Jatho A, Vettel C, Tiburcy M, Toischer K, Hasenfuss G, Zimmermann WH, Wieland T, Lutz S.

J Mol Cell Cardiol. 2015 Nov;88:39-54. doi: 10.1016/j.yjmcc.2015.09.009. Epub 2015 Sep 21.

PMID:
26392029
16.

Human Engineered Heart Muscles Engraft and Survive Long Term in a Rodent Myocardial Infarction Model.

Riegler J, Tiburcy M, Ebert A, Tzatzalos E, Raaz U, Abilez OJ, Shen Q, Kooreman NG, Neofytou E, Chen VC, Wang M, Meyer T, Tsao PS, Connolly AJ, Couture LA, Gold JD, Zimmermann WH, Wu JC.

Circ Res. 2015 Sep 25;117(8):720-30. doi: 10.1161/CIRCRESAHA.115.306985. Epub 2015 Aug 19.

17.

Physiologic force-frequency response in engineered heart muscle by electromechanical stimulation.

Godier-Furnémont AF, Tiburcy M, Wagner E, Dewenter M, Lämmle S, El-Armouche A, Lehnart SE, Vunjak-Novakovic G, Zimmermann WH.

Biomaterials. 2015 Aug;60:82-91. doi: 10.1016/j.biomaterials.2015.03.055. Epub 2015 May 15.

18.

Pre- and post-conditional inhibition of prolyl-4-hydroxylase domain enzymes protects the heart from an ischemic insult.

Vogler M, Zieseniss A, Hesse AR, Levent E, Tiburcy M, Heinze E, Burzlaff N, Schley G, Eckardt KU, Willam C, Katschinski DM.

Pflugers Arch. 2015 Oct;467(10):2141-9. doi: 10.1007/s00424-014-1667-z. Epub 2015 Jan 13.

PMID:
25578858
19.

Human immunoglobulin G for experimental treatment of Duchenne muscular dystrophy.

Zschüntzsch J, Jouvenal P, Zhang Y, Klinker F, Tiburcy M, Malzahn D, Liebetanz D, Brinkmeier H, Schmidt J.

Clin Exp Immunol. 2014 Dec;178 Suppl 1:132-3. doi: 10.1111/cei.12541. No abstract available.

20.

miR-133a enhances the protective capacity of cardiac progenitors cells after myocardial infarction.

Izarra A, Moscoso I, Levent E, Cañón S, Cerrada I, Díez-Juan A, Blanca V, Núñez-Gil IJ, Valiente I, Ruíz-Sauri A, Sepúlveda P, Tiburcy M, Zimmermann WH, Bernad A.

Stem Cell Reports. 2014 Dec 9;3(6):1029-42. doi: 10.1016/j.stemcr.2014.10.010. Epub 2014 Nov 20.

21.

Lights on for HIF-1α: genetically enhanced mouse cardiomyocytes for heart tissue imaging.

Hesse AR, Levent E, Zieseniss A, Tiburcy M, Zimmermann WH, Katschinski DM.

Cell Physiol Biochem. 2014;34(2):455-62. doi: 10.1159/000363014. Epub 2014 Jul 30.

22.

Collagen-based engineered heart muscle.

Tiburcy M, Meyer T, Soong PL, Zimmermann WH.

Methods Mol Biol. 2014;1181:167-76. doi: 10.1007/978-1-4939-1047-2_15.

PMID:
25070336
23.

Modeling myocardial growth and hypertrophy in engineered heart muscle.

Tiburcy M, Zimmermann WH.

Trends Cardiovasc Med. 2014 Jan;24(1):7-13. doi: 10.1016/j.tcm.2013.05.003. Epub 2013 Aug 15. Review.

PMID:
23953977
24.

Enhanced Ca²+ influx through cardiac L-type Ca²+ channels maintains the systolic Ca²+ transient in early cardiac atrophy induced by mechanical unloading.

Schwoerer AP, Neef S, Broichhausen I, Jacubeit J, Tiburcy M, Wagner M, Biermann D, Didié M, Vettel C, Maier LS, Zimmermann WH, Carrier L, Eschenhagen T, Volk T, El-Armouche A, Ehmke H.

Pflugers Arch. 2013 Dec;465(12):1763-73. doi: 10.1007/s00424-013-1316-y. Epub 2013 Jul 11.

25.

Cardiac differentiation of human embryonic stem cells and their assembly into engineered heart muscle.

Soong PL, Tiburcy M, Zimmermann WH.

Curr Protoc Cell Biol. 2012 Jun;Chapter 23:Unit23.8. doi: 10.1002/0471143030.cb2308s55.

PMID:
23129117
26.

Comparative study of human-induced pluripotent stem cells derived from bone marrow cells, hair keratinocytes, and skin fibroblasts.

Streckfuss-Bömeke K, Wolf F, Azizian A, Stauske M, Tiburcy M, Wagner S, Hübscher D, Dressel R, Chen S, Jende J, Wulf G, Lorenz V, Schön MP, Maier LS, Zimmermann WH, Hasenfuss G, Guan K.

Eur Heart J. 2013 Sep;34(33):2618-29. doi: 10.1093/eurheartj/ehs203. Epub 2012 Jul 12.

PMID:
22798560
27.

Terminal differentiation, advanced organotypic maturation, and modeling of hypertrophic growth in engineered heart tissue.

Tiburcy M, Didié M, Boy O, Christalla P, Döker S, Naito H, Karikkineth BC, El-Armouche A, Grimm M, Nose M, Eschenhagen T, Zieseniss A, Katschinksi DM, Hamdani N, Linke WA, Yin X, Mayr M, Zimmermann WH.

Circ Res. 2011 Oct 28;109(10):1105-14. doi: 10.1161/CIRCRESAHA.111.251843. Epub 2011 Sep 15.

28.

Extracellular signal-regulated kinases 1 and 2 regulate the balance between eccentric and concentric cardiac growth.

Kehat I, Davis J, Tiburcy M, Accornero F, Saba-El-Leil MK, Maillet M, York AJ, Lorenz JN, Zimmermann WH, Meloche S, Molkentin JD.

Circ Res. 2011 Jan 21;108(2):176-83. doi: 10.1161/CIRCRESAHA.110.231514. Epub 2010 Dec 2.

29.

PDGF-BB protects cardiomyocytes from apoptosis and improves contractile function of engineered heart tissue.

Vantler M, Karikkineth BC, Naito H, Tiburcy M, Didié M, Nose M, Rosenkranz S, Zimmermann WH.

J Mol Cell Cardiol. 2010 Jun;48(6):1316-23. doi: 10.1016/j.yjmcc.2010.03.008. Epub 2010 Mar 20.

PMID:
20307544
30.

Cardiac tissue engineering: a clinical perspective.

Zimmermann WH, Tiburcy M, Eschenhagen T.

Future Cardiol. 2007 Jul;3(4):435-45. doi: 10.2217/14796678.3.4.435. Review.

PMID:
21526914
31.

Heart muscle engineering: an update on cardiac muscle replacement therapy.

Zimmermann WH, Didié M, Döker S, Melnychenko I, Naito H, Rogge C, Tiburcy M, Eschenhagen T.

Cardiovasc Res. 2006 Aug 1;71(3):419-29. Epub 2006 Apr 7. Review.

PMID:
16697358
32.

Potential role of humoral immunity in cardiac dysfunction of patients suffering from dilated cardiomyopathy.

Staudt A, Staudt Y, Dörr M, Böhm M, Knebel F, Hummel A, Wunderle L, Tiburcy M, Wernecke KD, Baumann G, Felix SB.

J Am Coll Cardiol. 2004 Aug 18;44(4):829-36.

Supplemental Content

Loading ...
Support Center